Finch Therapeutics Group Inc logo

Finch Therapeutics Group Inc Share Price (NASDAQ: FNCH)

$12.05

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 22 Aug 2024

Check the interactive Finch Therapeutics Group Inc Stock chart to analyse performance

Finch Therapeutics Group Inc Key Stats

Check Finch Therapeutics Group Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$12.05
Open
$12.11
Market Capitalization
$17.7M
Today's Volume
$4.9K
Revenue TTM
$0.0
EBITDA
$-19.5M
Earnings Per Share (EPS)
$-8.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-67.28%

Global Institutional Holdings in Finch Therapeutics Group Inc

  • Name

    Holdings %

  • Susquehanna International Group, LLP

    3.68%

  • Vanguard Group Inc

    2.26%

  • Renaissance Technologies Corp

    0.73%

  • Ikarian Capital, LLC

    0.43%

  • Tower Research Capital LLC

    0.16%

  • Bleichroeder LP

    0.06%

Analyst Recommendation on Finch Therapeutics Group Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Finch Therapeutics Group Inc(by analysts ranked 0 to 5 stars)

About Finch Therapeutics Group Inc

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
Organization
Finch Therapeutics Group Inc
Employees
1
CEO
Mr. Matthew P. Blischak J.D.
Industry
Miscellaneous

Important FAQs about investing in FNCH Stock from India :

What is Finch Therapeutics Group Inc share price today?

Finch Therapeutics Group Inc share price today is $12.05 as on at the close of the market. Finch Therapeutics Group Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Finch Therapeutics Group Inc share?

Finch Therapeutics Group Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Finch Therapeutics Group Inc stock price today i.e. is closed at $12.05, lower by 10.21% versus the 52 week high.

How to invest in Finch Therapeutics Group Inc Stock (FNCH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Finch Therapeutics Group Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Finch Therapeutics Group Inc Shares that will get you 0.1245 shares as per Finch Therapeutics Group Inc share price of $12.05 per share as on August 22, 2024 at 12:00 am IST.

What is the minimum amount required to buy Finch Therapeutics Group Inc Stock (FNCH) from India?

Indian investors can start investing in Finch Therapeutics Group Inc (FNCH) shares with as little as ₹88.2687 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.69 in Finch Therapeutics Group Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Based on Finch Therapeutics Group Inc share’s latest price of $12.05 as on August 22, 2024 at 12:00 am IST, you will get 0.8299 shares of Finch Therapeutics Group Inc. Learn more about fractional shares .

What are the returns that Finch Therapeutics Group Inc has given to Indian investors in the last 5 years?

Finch Therapeutics Group Inc stock has given 0.0% share price returns and 20.27% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?